Tejas Patel, MD, MPH, MBA
Learn more about subscription options.
Register Now for a free account.
Patel T. In patients with type 2 diabetes and CVD, empagliflozin reduced incident or worsening nephropathy at 3.1 y. Ann Intern Med. 2016;165:JC39. doi: 10.7326/ACPJC-2016-165-8-039
Download citation file:
Published: Ann Intern Med. 2016;165(8):JC39.
Cardiology, Coronary Risk Factors, Diabetes, Diabetic Nephropathy, Endocrine and Metabolism.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only